Only with cydy would a $12M raise be considered a bad thing. Any other OTC stock getting that kind of offer, the sp would skyrocket. It took verb 1 year to get $16M so they go uplist to nasdaq. I saw a preclinical biotech nasdaq raise $3M last week and it crashed the sp.
Two more form 4s after hours, 2 more BOD participated in the TO.
Price action looked good today, maybe next week we get a 8x34 crossing boost... just maybe. I'll be glad when the BLA is submitted so we can leave some of these cockroaches feeding off cydy behind.